Cleerly LABS vs AI-ECG Tracker

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by Carewell Health

AI Verdict

Tool A (Cleerly LABS) is designed for comprehensive analysis of coronary CT angiography (CCTA) to assess atherosclerosis and stenosis, providing detailed anatomical insights for heart disease management. In contrast, Tool B (AI-ECG Tracker) focuses on the rapid, AI-powered auto-diagnosis of cardiac abnormalities from 12-lead ECG data, primarily identifying electrical signal irregularities. While both fall under Cardiology AI, they utilize distinct diagnostic modalities and serve different primary functions in patient evaluation.

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely detect, quantify, and characterize atherosclerosis and stenosis. This tool is ideal for personalized heart disease management, enabling detailed plaque assessment, risk stratification, and tracking disease progression over time. It provides in-depth anatomical and physiological insights for long-term preventative care.

View Cleerly LABS →

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your priority is rapid, highly accurate AI-powered auto-diagnosis of common cardiac abnormalities from 12-lead ECG data. This tool is best suited for immediate diagnostic support in settings like emergency medicine or for efficient screening in cardiology, providing quick insights into conditions such as arrhythmias, myocardial ischemia, and infarction in approximately three seconds.

View AI-ECG Tracker →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS AI-ECG Tracker
Pricing Per analysis Unknown
Deployment Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS AI-ECG Tracker
Tool Name Cleerly LABS AI-ECG Tracker
Company Cleerly Shenzhen Carewell Electronics Co.
Primary Modality/Input Coronary CT Angiography (CCTA) ECG data (12-lead)
Core AI Function Comprehensive analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis ECG auto-analysis and diagnosis for cardiac abnormalities
Key Diagnostic Output Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), personalized heart disease risk assessment High accuracy for common cardiac abnormalities including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; supports 16 cardiac classifications and 104 ECG diagnostic classifications

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and AI-ECG Tracker.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management and tracking disease progression. AI-ECG Tracker focuses on AI-powered auto-diagnosis of 12-lead ECG data for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
Cleerly LABS performs AI-powered analysis of coronary CT angiography (CCTA) images to assess coronary arteries. AI-ECG Tracker utilizes AI-powered auto-analysis of 12-lead ECG data for diagnostic purposes.
Cleerly LABS offers comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, 3D visualization, personalized risk assessment, and tracking disease progression. AI-ECG Tracker provides rapid diagnosis (approximately 3 seconds) with high accuracy for 16 cardiac classifications and 104 ECG diagnostic classifications, and includes a professional ECG diagnostic client for review, measurement, annotation, and report generation.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.